InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Skibsted Russell. Director active across 2 companies, notably Alimera Sciences INC. In total, 5 reports have been recorded. Split: 3 buys · 0 sell. Total volume traded: €15k. History available since 9 January 2023. The latest transaction was filed on 30 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
SKIBSTED RUSSELL is a declarant associated with Processa Pharmaceuticals, Inc. and Alimera Sciences INC, where the listed role is Chief Financial Officer, and Chief Financial Officer & SVP. Across 4 filings in total, the 4 sampled filings cover the period from 2023-01-10 to 2026-05-01 and show 10012 EUR of buys and 0 EUR of sells, with the modal transaction nature listed as Acquisition.